Forbion 2nd Annual Excellence Roundtable: The future of innovation in rare diseases

Forbion’s second annual Excellence Roundtable brought together investors, biotech leaders, clinicians, and patient advocates to explore the opportunities and challenges of rare disease innovation. The discussion highlighted the critical role of patient engagement, scientific advances, and long-term investment in developing therapies for diseases with significant unmet need. Panellists examined how collaboration across stakeholders, emerging technologies, and novel treatment platforms are accelerating progress while improving clinical trial design and patient outcomes. The session showcased Forbion’s longstanding commitment to rare disease investing and the broader impact of orphan disease research on advancing innovation across medicine.